Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

182

HTML

1395

Figures (1-1)

108

Tables (1-2)

121

Sum=1806

Jan 21, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jan 21, 2005; 11(3): 400-402
Published online Jan 21, 2005. doi: 10.3748/wjg.v11.i3.400

Figure 1 ALT activity in patients with chronic HBV infection treated with lamivudine.

Citation: Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol 2005; 11(3): 400-402
URL: https://www.wjgnet.com/1007-9327/full/v11/i3/400.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i3.400